Grifols reports continuing probe into possible FCPA violations
MLex Summary: Grifols, a Spanish pharmaceuticals group, said in a securities filing that it was continuing an internal investigation of possible Foreign Corrupt Practices Act violations in relation to its acquisiton...To view the full article, register now.
Already a subscriber? Click here to view full article